209 related articles for article (PubMed ID: 21149241)
1. Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.
Tadema H; Abdulahad WH; Lepse N; Stegeman CA; Kallenberg CG; Heeringa P
Rheumatology (Oxford); 2011 Apr; 50(4):689-96. PubMed ID: 21149241
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.
Lepse N; Land J; Rutgers A; Kallenberg CG; Stegeman CA; Abdulahad WH; Heeringa P
Rheumatology (Oxford); 2016 Jan; 55(1):162-72. PubMed ID: 26320128
[TBL] [Abstract][Full Text] [Related]
3. Pathogenesis of antimicrobial peptides LL-37 and CpG-ODN in ANCA associated vasculitis.
Luan JJ; Xing GQ
J Nephrol; 2017 Feb; 30(1):63-71. PubMed ID: 27476166
[TBL] [Abstract][Full Text] [Related]
4. Regulatory B cells in ANCA-associated vasculitis.
Wilde B; Thewissen M; Damoiseaux J; Knippenberg S; Hilhorst M; van Paassen P; Witzke O; Cohen Tervaert JW
Ann Rheum Dis; 2013 Aug; 72(8):1416-9. PubMed ID: 23666929
[TBL] [Abstract][Full Text] [Related]
5. In vitro cytokine production and proliferation of T cells from patients with anti-proteinase 3- and antimyeloperoxidase-associated vasculitis, in response to proteinase 3 and myeloperoxidase.
Popa ER; Franssen CF; Limburg PC; Huitema MG; Kallenberg CG; Tervaert JW
Arthritis Rheum; 2002 Jul; 46(7):1894-904. PubMed ID: 12124874
[TBL] [Abstract][Full Text] [Related]
6. CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitis.
Hurtado PR; Jeffs L; Nitschke J; Patel M; Sarvestani G; Cassidy J; Hissaria P; Gillis D; Peh CA
BMC Immunol; 2008 Jul; 9():34. PubMed ID: 18625057
[TBL] [Abstract][Full Text] [Related]
7. Intracellular cytokine production in ANCA-associated vasculitis: low levels of interleukin-10 in remission are associated with a higher relapse rate in the long-term follow-up.
Hruskova Z; Rihova Z; Mareckova H; Jancova E; Rysava R; Zavada J; Merta M; Löster T; Tesar V
Arch Med Res; 2009 May; 40(4):276-84. PubMed ID: 19608017
[TBL] [Abstract][Full Text] [Related]
8. Effect of high mobility group box 1 on Toll-like receptor 9 in B cells in myeloperoxidase-ANCA-associated vasculitis.
Wang C; Deng H; Gong Y; You R; Chen M; Zhao MH
Autoimmunity; 2020 Feb; 53(1):28-34. PubMed ID: 31790283
[TBL] [Abstract][Full Text] [Related]
9. Clinical and immunological features of drug-induced and infection-induced proteinase 3-antineutrophil cytoplasmic antibodies and myeloperoxidase-antineutrophil cytoplasmic antibodies and vasculitis.
Csernok E; Lamprecht P; Gross WL
Curr Opin Rheumatol; 2010 Jan; 22(1):43-8. PubMed ID: 19770659
[TBL] [Abstract][Full Text] [Related]
10. Regulation of myeloperoxidase-specific T cell responses during disease remission in antineutrophil cytoplasmic antibody-associated vasculitis: the role of Treg cells and tryptophan degradation.
Chavele KM; Shukla D; Keteepe-Arachi T; Seidel JA; Fuchs D; Pusey CD; Salama AD
Arthritis Rheum; 2010 May; 62(5):1539-48. PubMed ID: 20155828
[TBL] [Abstract][Full Text] [Related]
11. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of Toll-like receptors by monocytes and natural killer cells in ANCA-associated vasculitis.
Tadema H; Abdulahad WH; Stegeman CA; Kallenberg CG; Heeringa P
PLoS One; 2011; 6(9):e24315. PubMed ID: 21915309
[TBL] [Abstract][Full Text] [Related]
13. Increased levels of neutrophil extracellular trap remnants in the circulation of patients with small vessel vasculitis, but an inverse correlation to anti-neutrophil cytoplasmic antibodies during remission.
Söderberg D; Kurz T; Motamedi A; Hellmark T; Eriksson P; Segelmark M
Rheumatology (Oxford); 2015 Nov; 54(11):2085-94. PubMed ID: 26170375
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor TLR2 and TLR9 ligation triggers neutrophil activation in granulomatosis with polyangiitis.
Holle JU; Windmöller M; Lange C; Gross WL; Herlyn K; Csernok E
Rheumatology (Oxford); 2013 Jul; 52(7):1183-9. PubMed ID: 23407387
[TBL] [Abstract][Full Text] [Related]
15. Induction of remission by B lymphocyte depletion in eleven patients with refractory antineutrophil cytoplasmic antibody-associated vasculitis.
Keogh KA; Wylam ME; Stone JH; Specks U
Arthritis Rheum; 2005 Jan; 52(1):262-8. PubMed ID: 15641078
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the FIDIS vasculitis multiplex immunoassay for diagnosis and follow-up of ANCA-associated vasculitis and Goodpasture's disease.
Damoiseaux J; Vaessen M; Knapen Y; Csernok E; Stegeman CA; Van Paassen P; Tervaert JW
Ann N Y Acad Sci; 2007 Aug; 1109():454-63. PubMed ID: 17785334
[TBL] [Abstract][Full Text] [Related]
17. IgG from myeloperoxidase-antineutrophil cytoplasmic antibody-positive patients stimulates greater activation of primed neutrophils than IgG from proteinase 3-antineutrophil cytosplasmic antibody-positive patients.
Harper L; Radford D; Plant T; Drayson M; Adu D; Savage CO
Arthritis Rheum; 2001 Apr; 44(4):921-30. PubMed ID: 11315931
[TBL] [Abstract][Full Text] [Related]
18. Follow-up of avidity and titer of anti-myeloperoxidase antibodies in sera from patients with primary ANCA-associated vasculitis.
Lin W; Chen M; Zhao MH
Autoimmunity; 2009 Mar; 42(3):198-202. PubMed ID: 19301200
[TBL] [Abstract][Full Text] [Related]
19. Anti-neutrophil cytoplasmic antibodies predate symptom onset of ANCA-associated vasculitis. A case-control study.
Berglin E; Mohammad AJ; Dahlqvist J; Johansson L; Eriksson C; Sjöwall J; Rantapää-Dahlqvist S
J Autoimmun; 2021 Feb; 117():102579. PubMed ID: 33340843
[TBL] [Abstract][Full Text] [Related]
20. Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.
Lepse N; Abdulahad WH; Rutgers A; Kallenberg CG; Stegeman CA; Heeringa P
Rheumatology (Oxford); 2014 Sep; 53(9):1683-92. PubMed ID: 24729403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
